正确理解女性复发性应激性尿失禁治疗的随机试验中需要克服的挑战:PURSUIT随机对照试验

IF 3.5 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES
Caroline Pope, Madeleine Cochrane, Clare Clement, Yumeng Liu, Sangeetha Paramasivan, Sian Noble, Stephanie J MacNeill, Amanda L Lewis, Jodi Taylor, Bethanie Fitzgerald, Nikki Cotterill, Tamsin Greenwell, Hashim Hashim, Swati Jha, Nikesh Thiruchelvam, Philip Toozs-Hobson, Alison White, Wael Agur, J Athene Lane, Marcus Drake
{"title":"正确理解女性复发性应激性尿失禁治疗的随机试验中需要克服的挑战:PURSUIT随机对照试验","authors":"Caroline Pope, Madeleine Cochrane, Clare Clement, Yumeng Liu, Sangeetha Paramasivan, Sian Noble, Stephanie J MacNeill, Amanda L Lewis, Jodi Taylor, Bethanie Fitzgerald, Nikki Cotterill, Tamsin Greenwell, Hashim Hashim, Swati Jha, Nikesh Thiruchelvam, Philip Toozs-Hobson, Alison White, Wael Agur, J Athene Lane, Marcus Drake","doi":"10.3310/AKAK8992","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Recurrence or persistence of symptoms after interventions to treat stress urinary incontinence in women is common, but without robust evidence to base treatment recommendations.</p><p><strong>Objectives: </strong>To investigate whether endoscopic or surgical treatments for stress urinary incontinence in women are effective and cost-effective.</p><p><strong>Design: </strong>A multicentre, unblinded, parallel-group randomised controlled trial.</p><p><strong>Setting: </strong>Fifteen centres across the United Kingdom.</p><p><strong>Participants: </strong>Adult women with recurrent or persistent stress urinary incontinence.</p><p><strong>Intervention: </strong>Individual randomisation to endoscopic (urethral bulking) or surgical (autologous sling, colposuspension, artificial urinary sphincter) interventions. Women randomised to surgery chose their operative intervention.</p><p><strong>Main outcomes: </strong>Primary outcome self-reported International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form at 1 year post randomisation. Secondary outcomes included International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form, Patient Global Impression of Improvement and Pelvic Organ Prolapse/Urinary Incontinence Sexual questionnaires up to 3 years post randomisation, operative assessment measures and adverse events, cost-effectiveness from National Health Service and societal perspectives (quality-adjusted life-years and International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form) at 1 year, and a secondary care perspective (quality-adjusted life-years) at 3 years. Semistructured qualitative interviews at baseline (post randomisation), follow-up (3-6 months) and longer-term (12 and 36 months), to explore stress urinary incontinence generally, the acceptability and attitudes to treatments and to improve understanding of outcomes. Qualitative interviews with clinicians at baseline were focused on potential difficulties of recruitment and optimising patient-facing information and training materials for clinicians.</p><p><strong>Results: </strong>Fifty-five women were deemed eligible after screening (<i>n</i> = 328 screened) from October 2019 to June 2022. Twenty-four eligible women consented, and 23 were randomised (between January 2020 and July 2022) from 8 sites with the average age of 57 years (standard deviation: 10.7) and all self-reported 'white' ethnicity. Participants reported a median International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form score at baseline of 16 (interquartile range: 13-19) and mean post-void residual volume of 4.64 ml (standard deviation: 8.45). Eleven participants received their allocated intervention, 2 participants withdrew prior to receiving their intervention and 10 were waiting for their intervention when the study closed. The most common reason for declining participation was a treatment preference (<i>n</i> = 14). Recruitment training sessions and recruitment tips documents were developed and implemented to address challenges centred around patient treatment preferences and clinicians' equipoise. However, the most important recruitment challenge was the low number of eligible patients, driven primarily by the COVID-19 pandemic preventing referrals and surgery, and related wider issues in the National Health Service which led to study closure in January 2023.</p><p><strong>Conclusion: </strong>In its early stages, the initial recruitment rate was on target (four participants randomised in the first 3 months of recruitment), but once the pandemic started, the study was unable to recruit and so closed early. The main limitation was the occurrence of the global pandemic soon after the commencement of recruitment, profoundly affecting service delivery and patient presentations. Under normal healthcare service conditions, the study may be deliverable.</p><p><strong>Limitations: </strong>Failure to recruit under pandemic conditions rendered the study unfeasible.</p><p><strong>Future research: </strong>Practical experience with the study and development of patient-facing and staff training materials will help delivery of the study once patient referrals and healthcare services fully return to normal.</p><p><strong>Funding: </strong>This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number 17/95/03.</p>","PeriodicalId":12898,"journal":{"name":"Health technology assessment","volume":" ","pages":"1-43"},"PeriodicalIF":3.5000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Challenges to overcome in a randomised trial for Proper Understanding of Recurrent Stress Urinary Incontinence Treatment in women: the PURSUIT RCT.\",\"authors\":\"Caroline Pope, Madeleine Cochrane, Clare Clement, Yumeng Liu, Sangeetha Paramasivan, Sian Noble, Stephanie J MacNeill, Amanda L Lewis, Jodi Taylor, Bethanie Fitzgerald, Nikki Cotterill, Tamsin Greenwell, Hashim Hashim, Swati Jha, Nikesh Thiruchelvam, Philip Toozs-Hobson, Alison White, Wael Agur, J Athene Lane, Marcus Drake\",\"doi\":\"10.3310/AKAK8992\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Recurrence or persistence of symptoms after interventions to treat stress urinary incontinence in women is common, but without robust evidence to base treatment recommendations.</p><p><strong>Objectives: </strong>To investigate whether endoscopic or surgical treatments for stress urinary incontinence in women are effective and cost-effective.</p><p><strong>Design: </strong>A multicentre, unblinded, parallel-group randomised controlled trial.</p><p><strong>Setting: </strong>Fifteen centres across the United Kingdom.</p><p><strong>Participants: </strong>Adult women with recurrent or persistent stress urinary incontinence.</p><p><strong>Intervention: </strong>Individual randomisation to endoscopic (urethral bulking) or surgical (autologous sling, colposuspension, artificial urinary sphincter) interventions. Women randomised to surgery chose their operative intervention.</p><p><strong>Main outcomes: </strong>Primary outcome self-reported International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form at 1 year post randomisation. Secondary outcomes included International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form, Patient Global Impression of Improvement and Pelvic Organ Prolapse/Urinary Incontinence Sexual questionnaires up to 3 years post randomisation, operative assessment measures and adverse events, cost-effectiveness from National Health Service and societal perspectives (quality-adjusted life-years and International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form) at 1 year, and a secondary care perspective (quality-adjusted life-years) at 3 years. Semistructured qualitative interviews at baseline (post randomisation), follow-up (3-6 months) and longer-term (12 and 36 months), to explore stress urinary incontinence generally, the acceptability and attitudes to treatments and to improve understanding of outcomes. Qualitative interviews with clinicians at baseline were focused on potential difficulties of recruitment and optimising patient-facing information and training materials for clinicians.</p><p><strong>Results: </strong>Fifty-five women were deemed eligible after screening (<i>n</i> = 328 screened) from October 2019 to June 2022. Twenty-four eligible women consented, and 23 were randomised (between January 2020 and July 2022) from 8 sites with the average age of 57 years (standard deviation: 10.7) and all self-reported 'white' ethnicity. Participants reported a median International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form score at baseline of 16 (interquartile range: 13-19) and mean post-void residual volume of 4.64 ml (standard deviation: 8.45). Eleven participants received their allocated intervention, 2 participants withdrew prior to receiving their intervention and 10 were waiting for their intervention when the study closed. The most common reason for declining participation was a treatment preference (<i>n</i> = 14). Recruitment training sessions and recruitment tips documents were developed and implemented to address challenges centred around patient treatment preferences and clinicians' equipoise. However, the most important recruitment challenge was the low number of eligible patients, driven primarily by the COVID-19 pandemic preventing referrals and surgery, and related wider issues in the National Health Service which led to study closure in January 2023.</p><p><strong>Conclusion: </strong>In its early stages, the initial recruitment rate was on target (four participants randomised in the first 3 months of recruitment), but once the pandemic started, the study was unable to recruit and so closed early. The main limitation was the occurrence of the global pandemic soon after the commencement of recruitment, profoundly affecting service delivery and patient presentations. Under normal healthcare service conditions, the study may be deliverable.</p><p><strong>Limitations: </strong>Failure to recruit under pandemic conditions rendered the study unfeasible.</p><p><strong>Future research: </strong>Practical experience with the study and development of patient-facing and staff training materials will help delivery of the study once patient referrals and healthcare services fully return to normal.</p><p><strong>Funding: </strong>This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number 17/95/03.</p>\",\"PeriodicalId\":12898,\"journal\":{\"name\":\"Health technology assessment\",\"volume\":\" \",\"pages\":\"1-43\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-07-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Health technology assessment\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3310/AKAK8992\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health technology assessment","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3310/AKAK8992","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

背景:干预治疗压力性尿失禁后症状复发或持续是常见的,但没有强有力的证据来支持治疗建议。目的:探讨内窥镜或手术治疗女性压力性尿失禁是否有效和经济。设计:多中心、非盲、平行组随机对照试验。环境:在英国有15个中心。参与者:复发性或持续性压力性尿失禁的成年女性。干预:个体随机分为内窥镜(尿道膨胀)或手术(自体吊带、阴道悬吊、人工尿道括约肌)干预。随机接受手术的妇女选择手术干预。主要结局:主要结局:自我报告的国际失禁咨询问卷-尿失禁-短表在随机化后1年。次要结局包括国际失禁咨询问卷-尿失禁-简短形式,患者总体改善印象和盆腔器官脱垂/尿失禁随机分组后3年的性问卷,手术评估措施和不良事件,从国民健康服务和社会角度(质量调整生命年和国际咨询失禁问卷-尿失禁-简表)1年的成本效益,以及从二级保健角度(质量调整生命年)3年的成本效益。在基线(随机化后)、随访(3-6个月)和更长期(12和36个月)进行半结构化定性访谈,以探讨压力性尿失禁的一般情况、对治疗的可接受性和态度,并提高对结果的理解。在基线与临床医生的定性访谈集中在招募和优化面向患者的信息和临床医生培训材料的潜在困难。结果:从2019年10月到2022年6月,55名女性在筛查后被认为符合条件(n = 328)。24名符合条件的女性表示同意,其中23名是随机抽取的(在2020年1月至2022年7月之间),来自8个站点,平均年龄为57岁(标准差:10.7),所有女性都自称为“白人”种族。参与者报告了基线时尿失禁问卷-尿失禁-简短形式国际咨询得分的中位数为16(四分位数范围:13-19),平均尿后残余容量为4.64 ml(标准差:8.45)。11名参与者接受了分配给他们的干预,2名参与者在接受干预之前退出,10名参与者在研究结束时等待干预。减少参与的最常见原因是治疗偏好(n = 14)。制定和实施了招聘培训课程和招聘提示文件,以解决以患者治疗偏好和临床医生平衡为中心的挑战。然而,最重要的招募挑战是符合条件的患者数量少,这主要是由于COVID-19大流行预防转诊和手术,以及国家卫生服务体系中相关的更广泛问题,导致研究于2023年1月关闭。结论:在早期阶段,最初的招募率达到了目标(在招募的前3个月随机分配了4名参与者),但一旦大流行开始,该研究就无法招募,因此提前结束。主要的限制是在征聘开始后不久就发生了全球大流行病,严重影响了服务的提供和病人的就诊情况。在正常的医疗服务条件下,该研究可能是可交付的。局限性:未能在大流行条件下招募人员使研究不可行。未来研究:研究和开发面向患者和员工培训材料的实践经验将有助于在患者转诊和医疗保健服务完全恢复正常后交付研究。资助:本摘要介绍了由国家卫生与保健研究所(NIHR)卫生技术评估项目资助的独立研究,奖励号为17/95/03。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Challenges to overcome in a randomised trial for Proper Understanding of Recurrent Stress Urinary Incontinence Treatment in women: the PURSUIT RCT.

Background: Recurrence or persistence of symptoms after interventions to treat stress urinary incontinence in women is common, but without robust evidence to base treatment recommendations.

Objectives: To investigate whether endoscopic or surgical treatments for stress urinary incontinence in women are effective and cost-effective.

Design: A multicentre, unblinded, parallel-group randomised controlled trial.

Setting: Fifteen centres across the United Kingdom.

Participants: Adult women with recurrent or persistent stress urinary incontinence.

Intervention: Individual randomisation to endoscopic (urethral bulking) or surgical (autologous sling, colposuspension, artificial urinary sphincter) interventions. Women randomised to surgery chose their operative intervention.

Main outcomes: Primary outcome self-reported International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form at 1 year post randomisation. Secondary outcomes included International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form, Patient Global Impression of Improvement and Pelvic Organ Prolapse/Urinary Incontinence Sexual questionnaires up to 3 years post randomisation, operative assessment measures and adverse events, cost-effectiveness from National Health Service and societal perspectives (quality-adjusted life-years and International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form) at 1 year, and a secondary care perspective (quality-adjusted life-years) at 3 years. Semistructured qualitative interviews at baseline (post randomisation), follow-up (3-6 months) and longer-term (12 and 36 months), to explore stress urinary incontinence generally, the acceptability and attitudes to treatments and to improve understanding of outcomes. Qualitative interviews with clinicians at baseline were focused on potential difficulties of recruitment and optimising patient-facing information and training materials for clinicians.

Results: Fifty-five women were deemed eligible after screening (n = 328 screened) from October 2019 to June 2022. Twenty-four eligible women consented, and 23 were randomised (between January 2020 and July 2022) from 8 sites with the average age of 57 years (standard deviation: 10.7) and all self-reported 'white' ethnicity. Participants reported a median International Consultation on Incontinence Questionnaire-Urinary Incontinence-Short Form score at baseline of 16 (interquartile range: 13-19) and mean post-void residual volume of 4.64 ml (standard deviation: 8.45). Eleven participants received their allocated intervention, 2 participants withdrew prior to receiving their intervention and 10 were waiting for their intervention when the study closed. The most common reason for declining participation was a treatment preference (n = 14). Recruitment training sessions and recruitment tips documents were developed and implemented to address challenges centred around patient treatment preferences and clinicians' equipoise. However, the most important recruitment challenge was the low number of eligible patients, driven primarily by the COVID-19 pandemic preventing referrals and surgery, and related wider issues in the National Health Service which led to study closure in January 2023.

Conclusion: In its early stages, the initial recruitment rate was on target (four participants randomised in the first 3 months of recruitment), but once the pandemic started, the study was unable to recruit and so closed early. The main limitation was the occurrence of the global pandemic soon after the commencement of recruitment, profoundly affecting service delivery and patient presentations. Under normal healthcare service conditions, the study may be deliverable.

Limitations: Failure to recruit under pandemic conditions rendered the study unfeasible.

Future research: Practical experience with the study and development of patient-facing and staff training materials will help delivery of the study once patient referrals and healthcare services fully return to normal.

Funding: This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number 17/95/03.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Health technology assessment
Health technology assessment 医学-卫生保健
CiteScore
6.90
自引率
0.00%
发文量
94
审稿时长
>12 weeks
期刊介绍: Health Technology Assessment (HTA) publishes research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信